Literature DB >> 18420184

Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB.

Rui Wang1, Ying-Bo Li, Yu-Hua Li, Ying Xu, Hong-Li Wu, Xue-Jun Li.   

Abstract

Curcumin is a major active component isolated from Curcuma longa. Previously, we have reported its significant antidepressant effect. However, the mechanisms underlying the antidepressant effects are still obscure. In the present study, we explored the effect of curcumin against glutamate excitotoxicity, mainly focusing on the neuroprotective effects of curcumin on the expression of Brain-Derived Neurotrophic Factor (BDNF), which is deeply involved in the etiology and treatment of depression. Exposure of rat cortical neurons to 10 microM glutamate for 24 h caused a significant decrease in BDNF level, accompanied with reduced cell viability and enhanced cell apoptosis. Pretreatment of neurons with curcumin reversed the BDNF expression and cell viability in a dose- and time-dependent manner. However, K252a, a Trk receptor inhibitor which is known to inhibit the activity of BDNF, could block the survival-promoting effect of curcumin. In addition, the up-regulation of BDNF levels by curcumin was also suppressed by K252a. Taken together, these results suggest that the neuroprotective effect of curcumin might be mediated via BDNF/TrkB signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18420184     DOI: 10.1016/j.brainres.2008.01.104

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  38 in total

1.  The CB₁ receptor-mediated endocannabinoid signaling and NGF: the novel targets of curcumin.

Authors:  Parichehr Hassanzadeh; Anna Hassanzadeh
Journal:  Neurochem Res       Date:  2012-02-07       Impact factor: 3.996

2.  Neurite outgrowth effect of 4-O-methylhonokiol by induction of neurotrophic factors through ERK activation.

Authors:  Yong Kyoung Lee; Im Seop Choi; Young Heui Kim; Ki Ho Kim; Sang Yun Nam; Young Won Yun; Moon Soon Lee; Ki Wan Oh; Jin Tae Hong
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

3.  Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke Victims.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2011-06-01       Impact factor: 6.829

Review 4.  Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases.

Authors:  Amir Abbas Momtazi; Giuseppe Derosa; Pamela Maffioli; Maciej Banach; Amirhossein Sahebkar
Journal:  Mol Diagn Ther       Date:  2016-08       Impact factor: 4.074

Review 5.  Neurotrophin strategies for neuroprotection: are they sufficient?

Authors:  Joseph P Steiner; Avindra Nath
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-08       Impact factor: 4.147

Review 6.  Glutamate metabolism and HIV-associated neurocognitive disorders.

Authors:  Fabián J Vázquez-Santiago; Richard J Noel; James T Porter; Vanessa Rivera-Amill
Journal:  J Neurovirol       Date:  2014-05-28       Impact factor: 2.643

7.  Postnatal treatment using curcumin supplements to amend the damage in VPA-induced rodent models of autism.

Authors:  Maha Al-Askar; Ramesa Shafi Bhat; Manar Selim; Laila Al-Ayadhi; Afaf El-Ansary
Journal:  BMC Complement Altern Med       Date:  2017-05-10       Impact factor: 3.659

8.  Celastrol Dilates and Counteracts Ethanol-Induced Constriction of Cerebral Arteries.

Authors:  Kelsey North; Alexandria Slayden; Steven Mysiewicz; Anna Bukiya; Alex Dopico
Journal:  J Pharmacol Exp Ther       Date:  2020-08-29       Impact factor: 4.030

9.  An overview of curcumin in neurological disorders.

Authors:  S K Kulkarni; A Dhir
Journal:  Indian J Pharm Sci       Date:  2010-03       Impact factor: 0.975

Review 10.  BDNF mediates adaptive brain and body responses to energetic challenges.

Authors:  Krisztina Marosi; Mark P Mattson
Journal:  Trends Endocrinol Metab       Date:  2013-12-19       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.